Άρτεμις Καρκανάκη

• Επιστημονική Συνεργάτης της Δ’ Μαιευτικής και Γυναικολογικής Κλινικής Α.Π.Θ. 2005-2009
• Eπιστημονική συνεργάτης Κέντρου Εξωσωματικής Γονιμοποίησης στη Θεσσαλονίκη 2005-2009
• Χειρουργική Κλινική Νοσοκομείου Κατερίνης 2007-2008
• Μαιευτική-Γυναικολογική Κλινική Νοσοκομείου Γιαννιτσών 2009-2010
• Universitatsklinikum Schleswig-Holstein στο Lübeck της Γερμανίας, Μονάδα Ανθρώπινης Αναπαραγωγής 2011
• Γ’ Μαιευτική και Γυναικολογική Α.Π.Θ. Ιπποκράτειο Νοσοκομείο 2011-2013
• Reproductive Medicine Clinic, St’ Michael’s University Hospital Bristol 2014
• Herts and Essex Fertility Clinic, London, UK 2015
• Assisted Conception Unit Guy’s University Hospital, London το διάστημα 2015-2016
• Γυναικολόγος Χειρουργός Μαιευτήρας, Ιατρικά Υποβοηθούμενη Αναπαραγωγή, Διατήρηση γονιμότητας

Μητροπόλεως 76, Θεσσαλονίκη 2017-σήμερα

• Επιστημονική συνεργάτης Γ’ Μαιευτικής-Γυναικολογικής Κλινικής Α.Π.Θ. 2017-σήμερα
• Επιστημονική συνεργάτης FIVI 2023-σήμερα

• Επιστημονική Συνεργάτης ΑΠΘ
• Προσκεκλημένη ομιλήτρια σε μεταπτυχιακά προγράμματα(MSc Reproduction and Development at University of Bristol, UK)

• Μέλος ελληνικών και διεθνών επιστημονικών εταιρειών (Μαιευτική και Γυναικολογική Εταιρεία Θεσσαλονίκης, Ελληνική Εταιρεία Γονιμότητας και Στειρότητας, ΕΛΕΙΥΑ, ESHRE)
• Υποτροφία Erasmus, Βραβείο Ελληνικής Εταιρίας Ενδοκρινολογίας για πρωτότυπη έρευνα
• Πτυχία διδασκαλίας και γλωσσομάθειας σε τέσσερις ξένες γλώσσες

Fluorescence in situ hybridisation sperm examination is significantly impaired in all categories of male infertility

Petousis S, Prapas Y, Papatheodorou A, Margioula-Siarkou C, Papatzikas G, Panagiotidis Y, Karkanaki A, Ravanos K, Prapas N.

Andrologia. 2017 Aug 1. doi: 10.1111/and.12847

Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment

Daskalopoulos G, Karkanaki A, Piouka A, Prapas N, Panidis D, Gkeleris P, Athyros VG.

Curr Vasc Pharmacol. 2015;13(6):788-800.

Operator experience reduces the risk of second trimester amniocentesis-related adverse outcomes

Margioula-Siarkou C, Karkanaki A, Kalogiannidis I, Petousis S, Dagklis T, Mavromatidis G, Prapas Y, Prapas N, Rousso D.

Eur J Obstet Gynecol Reprod Biol. 2013 Jul;169(2):230-3. doi: 10.1016/j.ejogrb.2013.03.027.

Effect of short-term tibolone treatment on risk markers for cardiovascular disease in healthy postmenopausal women: a randomized controlled study

Traianos A, Vavilis D, Makedos A, Karkanaki A, Ravanos K, Prapas N, Tarlatzis BC.

Clin Exp Obstet Gynecol. 2013;40(4):542-5.

The impact of six-month tibolone postmenopausal treatment on cell adhesion molecules levels

Zografou C, Masouridou N, Karkanaki A, Karamouzis M, Vavilis D, Tarlatzis BC.

Clin Exp Obstet Gynecol. 2012;39(3):337-40.

Amniocentesis-related adverse outcomes according to placental location and risk factors for fetal loss after midtrimester amniocentesis

Kalogiannidis I, Prapa S, Dagklis T, Karkanaki A, Petousis S, Prapas Y, Prapas N.

Clin Exp Obstet Gynecol. 2011;38(3):239-42.

Comparative study of the intravenous chemoprophylaxix versus local Sulmycin® Implant E Sponge use in vaginal hysterectomy

Tsikouras P, Dafopoulos A, Zografou C, Karkanaki A, Tsigga E, Ammari A, Dafopoulos K, Galazios G, Liberis V, Teichmann AT.

Minim Invasive Ther Allied Technol. 2012 May;21(3):181-7

Serum anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum follicle stimulating hormone (FSH) levels

Panidis D, Katsikis I, Karkanaki A, Piouka A, Armeni AK, Georgopoulos NA.

Med Hypotheses. 2011 Oct;77(4):649-53.

The clinical significance of anti-Müllerian hormone evaluation in gynecological endocrinology

Karkanaki A, Vosnakis C, Panidis D.

Hormones (Athens). 2011 Apr-Jun;10(2):95-103. Review.

Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome?

Daskalopoulos GN, Karkanaki A, Karagiannis A, Mikhailidis DP, Athyros VG.

Angiology. 2011 May;62(4):285-90. doi: 10.1177/0003319711399571.

Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome

Katsikis I, Karkanaki A, Misichronis G, Delkos D, Kandaraki EA, Panidis D.

Eur J Obstet Gynecol Reprod Biol. 2011 Jun;156(2):181-5.

Amniocentesis-related adverse outcomes in diamniotic twins: is there a difference compared to singleton pregnancies?

Kalogiannidis I, Petousis S, Prapa S, Dagklis T, Karkanaki A, Prapas Y, Prapas N.

Eur J Obstet Gynecol Reprod Biol. 2011 Mar;155(1):23-6.

Hormone therapy and asymmetrical dimethylarginine in postmenopausal women

Karkanaki A, Vavilis D, Traianos A, Kalogiannidis I, Panidis D.

Hormones (Athens). 2010 Apr-Jun;9(2):127-35. Review.

Decreased active, total and altered active to total ghrelin ratio in normal weight women with the more severe form of polycystic ovary syndrome

Panidis D, Asteriadis C, Georgopoulos NA, Katsikis I, Zournatzi V, Karkanaki A, Saltamavros AD, Decavalas G, Diamanti-Kandarakis E.

Eur J Obstet Gynecol Reprod Biol. 2010 Apr;149(2):170-4.

Genetics of polycystic ovary syndrome

Prapas N, Karkanaki A, Prapas I, Kalogiannidis I, Katsikis I, Panidis D.

Hippokratia. 2009 Oct;13(4):216-23.

Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: study in normal weight, normoinsulinemic patients

Karkanaki A, Piouka A, Katsikis I, Farmakiotis D, Macut D, Panidis D.

Fertil Steril. 2009 Dec;92(6):2078-81.

Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study

Florakis D, Diamanti-Kandarakis E, Katsikis I, Nassis GP, Karkanaki A, Georgopoulos N, Panidis D.

Int J Obes (Lond). 2008 Apr;32(4):692-9. Epub 2007 Dec 11.

Is the Y chromosome all that is required for sex determination?

Karkanaki A, Praras N, Katsikis I, Kita M, Panidis D.

Hippokratia. 2007 Jul;11(3):120-3.

Anovulation and ovulation induction

Katsikis I, Kita M, Karkanaki A, Prapas N, Panidis D.

Hippokratia. 2006 Jul;10(3):120-7.

Late pregnancy complications in polycystic ovarian syndrome

Katsikis I, Kita M, Karkanaki A, Prapas N, Panidis D.

Hippokratia. 2006 Jul;10(3):105-11.